Jr. Stratton et al., IMAGING ARTERIAL THROMBOSIS - COMPARISON OF TC-99M-LABELED MONOCLONALANTIFIBRIN ANTIBODIES AND INDIUM-112 PLATELETS, The Journal of nuclear medicine, 35(11), 1994, pp. 1731-1737
Imaging with the Tc-99m-T2G1s monoclonal antifibrin antibody fragment
(Fab') has demonstrated promise in the noninvasive detection of venous
thrombi in humans. The purpose of this study was to determine whether
chronic arterial thrombi can also be detected by antifibrin antibody
imaging. Methods: Eighteen subjects with chronic arterial thrombi were
studied with planar and tomographic imaging at 0 to 24 hr postinjecti
on of Tc-99m-labeled T2G1s monoclonal antifibrin antibody fragment. Im
aging with In-111-labeled platelets was also performed. Images were vi
sually graded by two observers as 0, 1, 2 or 3 (no, faint, moderate or
marked) uptake, and quantitative analysis of tomographic images was d
one in 13 subjects. Results: On visual analysis of planar images, 44%(
8 of 18) of antifibrin patient studies were 1.0 or more and 66% (10 of
18) were judged negative compared with 94% (15 of 16) of platelet pat
ient studies judged 1.0 or more and 6% (1 of 16) judged as negative (p
< 0.01). Visual analysis of tomographic images was similar, with 61%
(11 of 18) of antifibrin studies graded 1.0 or more compared with 100%
(17 of 17) of platelet studies (p < 0.01). The tomographic target-to-
background ratio was higher with platelets than with antifibrin antibo
dy (2.5 +/- 1.4 versus 1.8 +/- 1.0, p < 0.05). Conclusion: In the larg
e-vessel chronic arterial thrombi studied, the results of Tc-99m-label
ed monoclonal T2G1s antifibrin Fab' imaging were positive in only one-
half of the patients studied, significantly less than the findings wit
h platelet imaging, which were positive in all subjects. The higher ra
te of positive images with labeled platelets than with labeled antifib
rin antibodies may be largely due to thrombus age, with continued plat
elet deposition but little active fibrin deposition.